Stay updated on Magrolimab Combos in Myeloid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combos in Myeloid Malignancies Clinical Trial page.

Latest updates to the Magrolimab Combos in Myeloid Malignancies Clinical Trial page
- Check2 days agoChange DetectedThe study has been terminated, and the sponsor has made a decision to end it. The results are now posted, indicating a significant update in the study's status.SummaryDifference2%
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.5%
- Check31 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check45 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check67 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
Stay in the know with updates to Magrolimab Combos in Myeloid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combos in Myeloid Malignancies Clinical Trial page.